Beijing, China

Yian Guo

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Beone Medicines | Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yian Guo. Retrieved from https://idiyas.com/inventor/yian-guo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yian Guo: Inventor in Pharmaceutical Research

Introduction

Yian Guo is an inventor associated with Beijing, China, whose patent work concerns pharmaceutical compounds and cancer research. He is affiliated with BeOne Medicines GmbH.

Latest Patents

Guo is listed as an inventor on 1 patent, titled “5-amino-6,8-dihydro-1H-furo[3,4-d]pyrrolo[3,2-b]pyridine-2-carboxamide derivatives as MTA-cooperative inhibitors of PRMT5.” The disclosure describes compounds intended to selectively inhibit PRMT5 in cooperation with MTA in tumors bearing MTAP mutations. It also discusses pharmaceutical compositions containing these compounds and their potential use in treating diseases, including cancer.

Career Highlights

The patent reflects Guo’s involvement in research focused on targeted therapeutic approaches and the development of compounds for potential medical applications. His listed company affiliation connects this work with BeOne Medicines GmbH.

Collaborations

The patent’s listed collaborators include Jing Li and Sanjia Xu, indicating a shared contribution to the disclosed research.

Conclusion

Yian Guo’s patent work centers on MTA-cooperative PRMT5 inhibitors and their potential application in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…